Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

44.31
Delayed Data
As of Sep 23
 -1.49 / -3.26%
Today’s Change
43.92
Today|||52-Week Range
59.40
-22.74%
Year-to-Date
Novo Nordisk (NVO) Presents Data on Obesity Drug Saxenda
Sep 15 / Zacks.com - Paid Partner Content
Why Novo Nordisk Stock Dropped 18.9% in August
Sep 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close45.80
Today’s open44.35
Day’s range44.24 - 45.00
Volume191,110
Average volume (3 months)63,010
Market cap$89.2B
Dividend yield2.09%
Data as of 1:25pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+12.17%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+1.54%
P/E ratio--
Price/Sales9.35
Price/Book16.51

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Search for Jobs